SlideShare une entreprise Scribd logo
1  sur  108
General Anesthetics Jieyu Fang The First Affiliated Hospital 房洁渝 中山大学附属第一医院
Principles of General Anesthesia ,[object Object],[object Object],[object Object]
 
What are General Anesthetics? ,[object Object],[object Object]
Background ,[object Object],[object Object],[object Object]
Anesthetics divide into 2 classes: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Hypotheses of General Anesthesia ,[object Object],[object Object],[object Object],[object Object]
Other Theories included ,[object Object],[object Object],[object Object],[object Object],[object Object]
GABA receptors  gamma- aminobutyric  acid   ,[object Object],[object Object],[object Object],[object Object]
GABA receptors ,[object Object]
NMDA receptor ,[object Object],[object Object],[object Object],[object Object]
Mechanism of Action ,[object Object],[object Object],[object Object],[object Object]
Mechanism ,[object Object],[object Object],[object Object],[object Object]
Intravenous Anesthetics  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pharmacology of intravenous (IV) anesthetics  ,[object Object],[object Object]
Pharmacology of intravenous (IV) anesthetics ,[object Object]
Pharmacology of intravenous (IV) anesthetics ,[object Object]
[object Object],[object Object]
Propofol ,[object Object]
 
propofol ,[object Object],[object Object],[object Object],[object Object]
propofol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Properties of Intravenous Anesthetic Agents-propofol ,[object Object],[object Object],[object Object],[object Object]
Dosages of commonly used IV anesthetics  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
propofol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepines ,[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepines ,[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepines ,[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepines ,[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepines ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Benzodiazepines ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Flumazenil   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Ketamine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ketamine ,[object Object],[object Object],[object Object],[object Object],[object Object]
Ketamine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ketamine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ketamine ,[object Object],[object Object],[object Object],[object Object]
Etomidate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Etomidate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Etomidate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Properties of Intravenous Anesthetic Agents Drug Induction and Recovery Main Unwanted Effects Notes thiopental Fast onset (accumulation occurs, giving slow recovery) Hangover Cardiovascular and respiratory depression Used as induction agent declining. ↓ CBF and O2 consumption Injection pain etomidate Fast onset, fairly fast recovery Excitatory effects during induction  Adrenocortical suppression Less cvs and resp depression than with thiopental,  Injection site pain propofol Fast onset, very fast recovery cvs and resp depression  Pain at injection site. Most common induction agent. Rapidly metabolized; possible to use as continuous infusion. Injection pain. Antiemetic ketamine Slow onset, after-effects common during recovery Psychotomimetic effects  following recovery, Postop nausea, vomiting ,  salivation Produces good  analgesia  and amnesia. No injection site pain midazolam Slower onset than other agents Minimal CV and resp effects. Little resp or cvs depression. No pain. Good amnesia.
Non-barbiturate induction drugs effects on BP and HR Drug Systemic BP Heart Rate propofol ↓ ↓ etomidate No change or  slight ↓ No change ketamine ↑ ↑
 
Opioids ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object]
Opioids ,[object Object],[object Object],[object Object]
Naloxone ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Naloxone ,[object Object],[object Object],[object Object],[object Object],[object Object]
Pharmacology of inhalation anesthetics ,[object Object]
minimum alveolar concentration ,[object Object],[object Object],[object Object],[object Object],[object Object]
MAC and Lipid Solubility 1.85 53 sevoflurane 105 1.4 nitrous oxide 1.90 65 ether 1.68 98 enflurane 0.76 224 halothane MAC Lipid/Gas Coefficient Agent
inhalation anesthetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
inhalation anesthetics ,[object Object],[object Object],[object Object],[object Object]
Uptake, Distribution and Elimination of Anesthetic Gases,  p29 0.74 1.68 1.15 2.05 104 MAC 3 1.4 Isoflurane 4 1.9 enflurane 6 12.1 ethyl ether 5 2.3 halothane 2 0.69 sevoflurane 1 0.47 N 2 O Rapidity of Onset Blood/Gas ( λ ) Agent
inhalation anesthetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
inhalation anesthetics ,[object Object],[object Object],[object Object]
inhalation anesthetics ,[object Object],[object Object],[object Object],[object Object]
inhalation anesthetics ,[object Object],[object Object],[object Object],[object Object]
Figure 11.2. Ratio of alveolar to inspired gas concentration (FA/FI) ,[object Object]
Nitrous oxide   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Volatile anesthetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Volatile anesthetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Volatile anesthetics ,[object Object],[object Object],[object Object],[object Object]
Volatile anesthetics ,[object Object],[object Object],[object Object],[object Object],[object Object]
Volatile anesthetics ,[object Object],[object Object],[object Object]
Nitrous oxide ,[object Object],[object Object]
Nitrous oxide ,[object Object],[object Object],[object Object],[object Object],[object Object]
Desflurane ,[object Object],[object Object]
Sevoflurane ,[object Object],[object Object]
Enflurane ,[object Object]
Inhalation Anesthetic Agents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
yes Marked Yes Yes  Respir depression No Significant  Significant No Respir irritation Slightly reduced Stable Slightly reduced Reduced Cardiac output Stable Increased Increased Reduced Heart rate Significant Significant Significant Moderate Muscle relax 3 – 6% 0.02% 0.2% 12 – 25% Metabolism No No No Yes Hepatotoxic Fast Very fast Moderate Slow Recovery Fast Fast Moderate Slow Alveolar equilibration sevoflurane Desflurane Isoflurane Halothane
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
 
 
 
 
 
 
Thank you!
 
 
Overview of Discussion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Historical Perspective ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],19 th  Century physician administering chloroform
Definition of General Anesthesia ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Body and General Anesthesia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mechanism ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cellular Mechanism ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Structures ,[object Object],[object Object],Propofol Etomidate Ketamine Halothane Isoflurane Sevoflurane
Molecular Actions: GABA A  Receptor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Molecular Actions: GABA A  Receptor ,[object Object],[object Object],[object Object],[object Object]
Molecular Action: GABA A  Receptor
Molecular Action: GABA A  Receptor ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mechanism of Propofol ,[object Object],[object Object],[object Object],[object Object],[object Object]
Mechanism of Propofol ,[object Object],[object Object],[object Object],[object Object],[object Object]
Mechanism of Propofol ,[object Object],[object Object],[object Object],[object Object]
Metabolism and Toxicity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adverse Effects of Propofol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Latest Discoveries:  Implications for the Medicinal Chemist ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Inhaled Anesthetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?
meducationdotnet
 
General anesthesia
General anesthesiaGeneral anesthesia
General anesthesia
DR POOJA
 

Tendances (20)

Pharmacokinetics of Inhalational Anaesthetics
Pharmacokinetics of Inhalational AnaestheticsPharmacokinetics of Inhalational Anaesthetics
Pharmacokinetics of Inhalational Anaesthetics
 
intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole...
 intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole... intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole...
intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole...
 
Ropivacaine vs Bupivacaine
Ropivacaine vs Bupivacaine Ropivacaine vs Bupivacaine
Ropivacaine vs Bupivacaine
 
Neuromuscular blockade & Reversal agents & Monitoring
Neuromuscular blockade & Reversal agents & Monitoring  Neuromuscular blockade & Reversal agents & Monitoring
Neuromuscular blockade & Reversal agents & Monitoring
 
Inhalational anesthetics
Inhalational anestheticsInhalational anesthetics
Inhalational anesthetics
 
Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?Sugammadex - a revolution in anaesthesia?
Sugammadex - a revolution in anaesthesia?
 
Halothane by Dr. Aram Shah
Halothane by Dr. Aram ShahHalothane by Dr. Aram Shah
Halothane by Dr. Aram Shah
 
Suxamethonium
Suxamethonium Suxamethonium
Suxamethonium
 
General anesthesia
General anesthesiaGeneral anesthesia
General anesthesia
 
Opioids & Their Use in Anaesthesia
Opioids & Their Use in Anaesthesia Opioids & Their Use in Anaesthesia
Opioids & Their Use in Anaesthesia
 
Local anesthetics and additives
Local anesthetics and additives Local anesthetics and additives
Local anesthetics and additives
 
caudal anesthesia.pdf
caudal anesthesia.pdfcaudal anesthesia.pdf
caudal anesthesia.pdf
 
Intravenous Induction agents
Intravenous Induction agentsIntravenous Induction agents
Intravenous Induction agents
 
Context-Sensitive Half-Time in Anaesthetic Practice
Context-Sensitive Half-Time in Anaesthetic PracticeContext-Sensitive Half-Time in Anaesthetic Practice
Context-Sensitive Half-Time in Anaesthetic Practice
 
Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine, Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine,
 
Inhalational Anesthetic Agents
Inhalational Anesthetic AgentsInhalational Anesthetic Agents
Inhalational Anesthetic Agents
 
Halothane
HalothaneHalothane
Halothane
 
Question & answer session on anaesthetic drugs
Question & answer session on anaesthetic drugsQuestion & answer session on anaesthetic drugs
Question & answer session on anaesthetic drugs
 
dr. Takdir - safety profile of bupivacaine in neuraxial analgesia
dr. Takdir - safety profile of bupivacaine in neuraxial analgesiadr. Takdir - safety profile of bupivacaine in neuraxial analgesia
dr. Takdir - safety profile of bupivacaine in neuraxial analgesia
 
Premedicant drugs / premedication
Premedicant drugs / premedicationPremedicant drugs / premedication
Premedicant drugs / premedication
 

Similaire à 3 general anethesia

Sedative-Hypnotic Drugs
Sedative-Hypnotic DrugsSedative-Hypnotic Drugs
Sedative-Hypnotic Drugs
shabeel pn
 
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharmaSEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
NimaFartash
 
ANAESTHESIA-INTRAVENOUS
ANAESTHESIA-INTRAVENOUSANAESTHESIA-INTRAVENOUS
ANAESTHESIA-INTRAVENOUS
shrinathraman
 
Anxiolytics Ol 2002
Anxiolytics Ol 2002Anxiolytics Ol 2002
Anxiolytics Ol 2002
danisepe
 

Similaire à 3 general anethesia (20)

Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugs
 
Class sedatives and hypnotics 2
Class sedatives and hypnotics 2Class sedatives and hypnotics 2
Class sedatives and hypnotics 2
 
Anaesthetic considerations for intraoperative neurophysiological monitoring
Anaesthetic considerations for intraoperative neurophysiological monitoringAnaesthetic considerations for intraoperative neurophysiological monitoring
Anaesthetic considerations for intraoperative neurophysiological monitoring
 
Sedative-Hypnotic Drugs
Sedative-Hypnotic DrugsSedative-Hypnotic Drugs
Sedative-Hypnotic Drugs
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
 
Sedative and hypnotic
Sedative and hypnoticSedative and hypnotic
Sedative and hypnotic
 
Drugs that act on CNS
Drugs that act on CNSDrugs that act on CNS
Drugs that act on CNS
 
General Anesthetics
General AnestheticsGeneral Anesthetics
General Anesthetics
 
Drugs That Act In The Central Nervous System
Drugs That Act In The Central Nervous SystemDrugs That Act In The Central Nervous System
Drugs That Act In The Central Nervous System
 
ppt 1.pptx
ppt 1.pptxppt 1.pptx
ppt 1.pptx
 
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharmaSEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
 
Cns depressents
Cns depressents Cns depressents
Cns depressents
 
OPIOIDS ii.pptx
OPIOIDS ii.pptxOPIOIDS ii.pptx
OPIOIDS ii.pptx
 
INTRAVENOUS INDUCTION AGENTS IN ANESTHESIA .pptx
INTRAVENOUS INDUCTION AGENTS IN ANESTHESIA .pptxINTRAVENOUS INDUCTION AGENTS IN ANESTHESIA .pptx
INTRAVENOUS INDUCTION AGENTS IN ANESTHESIA .pptx
 
Drugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxDrugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptx
 
ANAESTHESIA-INTRAVENOUS
ANAESTHESIA-INTRAVENOUSANAESTHESIA-INTRAVENOUS
ANAESTHESIA-INTRAVENOUS
 
Anxiolytics Ol 2002
Anxiolytics Ol 2002Anxiolytics Ol 2002
Anxiolytics Ol 2002
 
Drugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptxDrugs-acting-on-somatic-nervous-system.pptx
Drugs-acting-on-somatic-nervous-system.pptx
 
Sedatives and hypnotics (1)
Sedatives and hypnotics (1)Sedatives and hypnotics (1)
Sedatives and hypnotics (1)
 
Sedatives and hypnotics (1)
Sedatives and hypnotics (1)Sedatives and hypnotics (1)
Sedatives and hypnotics (1)
 

Plus de Sumit Prajapati

Pericardial abnormal findings
Pericardial abnormal findingsPericardial abnormal findings
Pericardial abnormal findings
Sumit Prajapati
 
Diagnostic radiology of cardiovascular 2009
Diagnostic radiology of cardiovascular 2009Diagnostic radiology of cardiovascular 2009
Diagnostic radiology of cardiovascular 2009
Sumit Prajapati
 
20100603 acute glomerulonephritis
20100603 acute glomerulonephritis20100603 acute glomerulonephritis
20100603 acute glomerulonephritis
Sumit Prajapati
 
1 introduction of epidmiology
1 introduction of epidmiology1 introduction of epidmiology
1 introduction of epidmiology
Sumit Prajapati
 
Anesthesia outside the operating room
Anesthesia outside the operating roomAnesthesia outside the operating room
Anesthesia outside the operating room
Sumit Prajapati
 
Neonatal cold injury syndrome
Neonatal cold injury syndromeNeonatal cold injury syndrome
Neonatal cold injury syndrome
Sumit Prajapati
 
C:\Documents And Settings\Administrator\桌面\13 Uri
C:\Documents And Settings\Administrator\桌面\13 UriC:\Documents And Settings\Administrator\桌面\13 Uri
C:\Documents And Settings\Administrator\桌面\13 Uri
Sumit Prajapati
 
C:\documents and settings\administrator\桌面\11 fluid therapy
C:\documents and settings\administrator\桌面\11 fluid therapyC:\documents and settings\administrator\桌面\11 fluid therapy
C:\documents and settings\administrator\桌面\11 fluid therapy
Sumit Prajapati
 
Administration of general anesthesia
Administration of general anesthesiaAdministration of general anesthesia
Administration of general anesthesia
Sumit Prajapati
 
1 evaluating the patient before the anesthesia(2009.2.23 27)
1 evaluating the patient before the anesthesia(2009.2.23 27)1 evaluating the patient before the anesthesia(2009.2.23 27)
1 evaluating the patient before the anesthesia(2009.2.23 27)
Sumit Prajapati
 
9 tuberculosis tanweiping
9 tuberculosis tanweiping9 tuberculosis tanweiping
9 tuberculosis tanweiping
Sumit Prajapati
 

Plus de Sumit Prajapati (20)

Pericardial abnormal findings
Pericardial abnormal findingsPericardial abnormal findings
Pericardial abnormal findings
 
Diagnostic radiology of cardiovascular 2009
Diagnostic radiology of cardiovascular 2009Diagnostic radiology of cardiovascular 2009
Diagnostic radiology of cardiovascular 2009
 
20100603 acute glomerulonephritis
20100603 acute glomerulonephritis20100603 acute glomerulonephritis
20100603 acute glomerulonephritis
 
05 diagnostic tests cwq
05 diagnostic tests cwq05 diagnostic tests cwq
05 diagnostic tests cwq
 
3 cross sectional study
3 cross sectional study3 cross sectional study
3 cross sectional study
 
3 cross sectional study
3 cross sectional study3 cross sectional study
3 cross sectional study
 
2.epidemilogic measures
2.epidemilogic measures2.epidemilogic measures
2.epidemilogic measures
 
1 introduction of epidmiology
1 introduction of epidmiology1 introduction of epidmiology
1 introduction of epidmiology
 
Anesthesia outside the operating room
Anesthesia outside the operating roomAnesthesia outside the operating room
Anesthesia outside the operating room
 
Neonatal septicemia
Neonatal septicemiaNeonatal septicemia
Neonatal septicemia
 
Neonatal cold injury syndrome
Neonatal cold injury syndromeNeonatal cold injury syndrome
Neonatal cold injury syndrome
 
C:\Documents And Settings\Administrator\桌面\13 Uri
C:\Documents And Settings\Administrator\桌面\13 UriC:\Documents And Settings\Administrator\桌面\13 Uri
C:\Documents And Settings\Administrator\桌面\13 Uri
 
C:\documents and settings\administrator\桌面\11 fluid therapy
C:\documents and settings\administrator\桌面\11 fluid therapyC:\documents and settings\administrator\桌面\11 fluid therapy
C:\documents and settings\administrator\桌面\11 fluid therapy
 
08 pain lishangrong 2
08 pain lishangrong 208 pain lishangrong 2
08 pain lishangrong 2
 
Administration of general anesthesia
Administration of general anesthesiaAdministration of general anesthesia
Administration of general anesthesia
 
5 regional anesthesia
5 regional anesthesia5 regional anesthesia
5 regional anesthesia
 
2 safety in anesthesia
2 safety in anesthesia2 safety in anesthesia
2 safety in anesthesia
 
1 evaluating the patient before the anesthesia(2009.2.23 27)
1 evaluating the patient before the anesthesia(2009.2.23 27)1 evaluating the patient before the anesthesia(2009.2.23 27)
1 evaluating the patient before the anesthesia(2009.2.23 27)
 
9 tuberculosis tanweiping
9 tuberculosis tanweiping9 tuberculosis tanweiping
9 tuberculosis tanweiping
 
8 measles
8 measles8 measles
8 measles
 

Dernier

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Dernier (20)

Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 

3 general anethesia

  • 1. General Anesthetics Jieyu Fang The First Affiliated Hospital 房洁渝 中山大学附属第一医院
  • 2.
  • 3.  
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.  
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.  
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42. Properties of Intravenous Anesthetic Agents Drug Induction and Recovery Main Unwanted Effects Notes thiopental Fast onset (accumulation occurs, giving slow recovery) Hangover Cardiovascular and respiratory depression Used as induction agent declining. ↓ CBF and O2 consumption Injection pain etomidate Fast onset, fairly fast recovery Excitatory effects during induction Adrenocortical suppression Less cvs and resp depression than with thiopental, Injection site pain propofol Fast onset, very fast recovery cvs and resp depression Pain at injection site. Most common induction agent. Rapidly metabolized; possible to use as continuous infusion. Injection pain. Antiemetic ketamine Slow onset, after-effects common during recovery Psychotomimetic effects following recovery, Postop nausea, vomiting , salivation Produces good analgesia and amnesia. No injection site pain midazolam Slower onset than other agents Minimal CV and resp effects. Little resp or cvs depression. No pain. Good amnesia.
  • 43. Non-barbiturate induction drugs effects on BP and HR Drug Systemic BP Heart Rate propofol ↓ ↓ etomidate No change or slight ↓ No change ketamine ↑ ↑
  • 44.  
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57. MAC and Lipid Solubility 1.85 53 sevoflurane 105 1.4 nitrous oxide 1.90 65 ether 1.68 98 enflurane 0.76 224 halothane MAC Lipid/Gas Coefficient Agent
  • 58.
  • 59.
  • 60. Uptake, Distribution and Elimination of Anesthetic Gases, p29 0.74 1.68 1.15 2.05 104 MAC 3 1.4 Isoflurane 4 1.9 enflurane 6 12.1 ethyl ether 5 2.3 halothane 2 0.69 sevoflurane 1 0.47 N 2 O Rapidity of Onset Blood/Gas ( λ ) Agent
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78. yes Marked Yes Yes Respir depression No Significant Significant No Respir irritation Slightly reduced Stable Slightly reduced Reduced Cardiac output Stable Increased Increased Reduced Heart rate Significant Significant Significant Moderate Muscle relax 3 – 6% 0.02% 0.2% 12 – 25% Metabolism No No No Yes Hepatotoxic Fast Very fast Moderate Slow Recovery Fast Fast Moderate Slow Alveolar equilibration sevoflurane Desflurane Isoflurane Halothane
  • 79.
  • 80.
  • 81.  
  • 82.  
  • 83.  
  • 84.  
  • 85.  
  • 86.  
  • 88.  
  • 89.  
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105.
  • 106.  
  • 107.
  • 108.